Australia: Food and Drugs Law

A case on appeal in NSW focused on whether a sentence handed down for drug supply charges was excessive.

Synergistic combinations in patent law present unique challenges for inventors in chemical, pharmaceutical, and life sciences fields. While combining known components is common practice, only those combinations producing effects greater than the sum of their parts can constitute patentable inventions. This article explores the legal requirements, evidentiary standards, and practical strategies for successfully claiming synergistic effects under Australian patent law.

Australia's pharmaceutical patent landscape has reached a critical juncture, with appellate courts reconsidering fundamental principles of patent scope, term extensions, and remedies that will shape originator-generic disputes for the foreseeable future. As the High Court prepares to rule on patent term extensions for formulation patents and new Federal Court practice directions take effect, the strategic calculus for both innovators and generic entrants is being fundamentally rewritten.

Product recall for several soft cheese products due to a potential contamination with deadly Listeria monocytogenes.

This article explains what the new changes are, what to expect as a business owner, and how we can assist you in navigating through these complicated new changes.

FTI Consulting's unique combination of financial expertise and practical farming knowledge positions the firm to build trust between investors and operators.

Recent death exposed the flaws in the VAD process in Queensland.

Following QPBO Act changes, here sets out what steps should be taken now depending on how a pharmacy business is currently structured.

The legal status of ayahuasca and potential criminal consequences if you were to use it.